Hospital pharmacists can play an instrumental role in controlling the misuse of opioids while ensuring appropriate pain management for their patients.
Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
Pharmacists can address the needs of health care consumers earlier in the care journey by building interpersonal relationships and community trust, as well as by leading institutional and public policy reform.
Current guideline recommendations include various combinations of targeted therapy with immunotherapy.
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
When a patient is engaged in the home by a team that includes a pharmacist resource, social determinants of health issues become more clear and the care team can help close the gaps.
Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.
Government’s database include health care professionals in many categories, including pharmacists.
Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Periodontitis and AD are both characterized by inflammatory and immunological response by the host.
Let’s shine the spotlight on ourselves, and let’s begin to heal.
Pharmacists can step up counseling and advocate for best practices for children with chronic illnesses.
Pharmacist-led post-cardiovascular surgery outpatient glycemic management services help reduce hospital readmissions and sternal wound infections in patients with uncontrolled diabetes who recently underwent an interventional cardiology procedure.
It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.
Specialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.
A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
New technology and innovation may help turn the corner on antibiotic resistance.
Technology is key in supporting and freeing up time for pharmacists to meet vaccination efforts and increased demands in providing community care.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.
Through recognizing the importance of research in the scope of pharmacy practice by national pharmacy organizations, research can become a prominent role and responsibility of pharmacy.
Like most of us who pursue a career in health care, I want to help as many people as I can. I also want to continue to advocate for underrepresented minorities who would like a career in the field.
Drug shortages, infrastructure and wholesaler challenges will be the backdrops of the pharmacy landscape this year.
Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.
Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.
We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.
Precise, more potent therapy can offer reduced toxicity.